177Lu-DOTA–PR81

N/A

Report date: 2025/11/14 17:20:04

Base Information

Drug Name177Lu-DOTA–PR81

Drug Alias Name177Lu conjugated PR81

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-MUC1

TargetsMucin-1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIslamic Azad University

China Registration ClassN/A

Develop Information

Active CompaniesIslamic Azad University

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A